<DOC>
	<DOCNO>NCT00286871</DOCNO>
	<brief_summary>Liver transplant subject give Mycophenolate ( MMF ) Tacrolimus order help prevent post-transplant rejection .</brief_summary>
	<brief_title>Randomized Controlled Trial Liver Transplant Recipients Treated Steroid Sparing Regimen</brief_title>
	<detailed_description>Recurrent HCV liver allograft become leading indicator retransplantation . Studies suggest glucocorticord-based immunosuppression regimen hasten onset progression recurrent chronic HCV liver disease . Treatment acute allograft rejection steroid bolus also associate rapid HCV recurrence . The relative contribution various calcineurin inhibitor recurrent HCV liver disease establish . Previous retrospective study , well prospective study demonstrate difference recurrent HCV liver disease rate patient receive CsA tacrolimus immunosuppression regimens respectively .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>adult patient receive liver transplant pregnant woman nurse woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2006</verification_date>
</DOC>